Views & Analysis Next wave: how pharma analytics can be improved with new tec... Pharmaceutical companies have always had access to a steady stream of data to look at what has happened in the past and to try to predict future prescribing trends.
Views & Analysis How digital is reversing fortunes in R&D A new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma R&D.
Events Partner Content 2019 Indegene Digital Summit - From Blockbuster Drugs to Blo... First-of-its-kind summit for Pharma & Biotech
Partner Content Partner Content Understanding the Medical Continuum Building a full picture of the development of a drug can be a time-consuming process.
Partner Content Partner Content “The important thing is to not stop questioning.” (Albert Ei... Intuition and experience – the ideal combination for finding a solution to an issue… or is it?
Partner Content Partner Content Making medical affairs a strategic advantage Medical Affairs was once seen as a supportive role, but today a good team can be a strategic advantage.
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face